06-01].6. Hammond J, Leister-Tebbe H, Gardner A, et al. Oral Nirmatrelvir for High-Risk
IGHV 突变 CLL 患者骨髓 uMRD 率较低但 36 个月 PFS 率较高参考文献:1. Allan JN, et al. Outcomes in Patients with High-Risk
和心血管疾病的发生风险。总之,该饮食建议符合EAT-Lancet未来可持续饮食指南,临床可向家长推荐该饮食模式。参考文献Hendriksen RB, van der Gaag EJ., high
功能丧失)和适应性策略(如用于克服残疾的行为改变)促进神经系统的恢复。需要进一步的研究来了解危重病期间早期职业治疗的生物学益处。】--quality evidence. High rates
2022:12.17. Jian-Feng Zhang, John P Williams, Qian-Nan Zhao, Hui Liu, Jian-Xiong An. Combined high
al. Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax
Wen T, Liu D, Shao J, Zhao L, Gao Q. Effect of 32-Weeks High-: Focus on Endogenous Apoptosis